YVETTE HERRINGTON: Open Payments
NPI 1457851552 · SUN CITY CENTER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 61 payments from 30 companies in 2025. Trend: 2023 $1,067 · 2024 $875 · 2025 $1,508
Food & beverage: $1,409Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $158 |
| Incyte Corporation | 3 | $149 |
| Janssen Biotech, Inc. | 6 | $141 |
| Astellas Pharma US Inc | 4 | $116 |
| Celgene Corporation | 3 | $87 |
| ARRAY BIOPHARMA INC | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| TAIHO ONCOLOGY, INC. | 3 | $61 |
| Alexion Pharmaceuticals, Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $51 |
Products named: Vyloy, REBLOZYL, TECVAYLI, Nubeqa, RYBREVANT, LONSURF, ULTOMIRIS, Fabhalta.
Industry payments across FL — which companies pay providers there.
